Patent details

Basic Information

Publication number:

EP2222706

PCT Application Number:

PCT/EP/2008/067499

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088617063

PCT Publication Number:

WO/2009/077483

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES AGAINST HUMAN NKG2D AND USES THEREOF

French Title of Invention:

ANTICORPS CONTRE NKG2D HUMAIN ET USAGES CORRESPONDANTS

German Title of Invention:

ANTIKÖRPER GEGEN MENSCHLICHES NKG2D UND GEBRAUCH DAVON

SPC Number:

Dates

Filing date:

15/12/2008

Grant date:

23/04/2014

EP Publication Date:

23/04/2014

PCT Publication Date:

25/06/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/09/2010

EP B1 Publication Date:

23/04/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/12/2014

Expiration date:

15/12/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/12/2008

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

SVENSSON Anders

Address:

Sweden (SE)

2

Name:

URSØ Birgitte

Address:

Denmark (DK)

3

Name:

WAGTMANN Peter Andreas Nicolai Reumert

Address:

Denmark (DK)

4

Name:

PEDERSEN Inger Lund

Address:

Denmark (DK)

Priority

1

Priority Number:

7/063979

Priority Date:

14/12/2007

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

08163163

Priority Date:

28/08/2008

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07K 16/28;

Filing date	Document type	Number of pages